PRESS RELEASE published on 07/15/2026 at 17:45, 3 months ago Inside Information / Other news releases Medincell aligns debt maturity with expected revenue growth trajectory by securing €28 million non-dilutive new bank loans and early repayment of €20 million EIB credit facility tranche Revenue Growth Debt Maturity Medincell Bank Loans EIB Credit Facility
BRIEF published on 06/16/2026 at 21:21, 3 months 29 days ago Medincell: Key Results and Initiatives for 2025-2026 Innovation Treasury R&D Royalties Medincell
BRIEF published on 05/21/2026 at 19:29, 4 months 25 days ago EMA Accepts Teva's Application for Long-Acting Schizophrenia Treatment Schizophrenia Treatment Teva Pharmaceuticals EMA Approval Olanzapine Injectable Long-acting Formulation
PRESS RELEASE published on 05/21/2026 at 19:24, 4 months 25 days ago Inside Information / Other news releases European Medicines Agency accepts Teva's Marketing Authorization Application for Olanzapine Long-Acting Injectable to treat schizophrenia in adults. Teva and Medincell announce EMA acceptance for innovative treatment option Schizophrenia Medincell Olanzapine Teva EMA
BRIEF published on 04/29/2026 at 13:44, 5 months 16 days ago Impressive sales growth for UZEDY® in Q1 2026 Schizophrenia Medincell Teva Pharmaceuticals UZEDY® Q1 2026 Sales
BRIEF published on 04/29/2026 at 13:44, 5 months 16 days ago UZEDY® Q1 2026 Sales Surge by 62% FDA Approvals Olanzapine LAI UZEDY® Sales Teva Partnership Medincell Growth
PRESS RELEASE published on 04/29/2026 at 13:39, 5 months 16 days ago Inside Information / Other news releases Medincell's partner Teva Pharmaceuticals reports UZEDY Q1 2026 net sales of $63M, a 62% increase year-on-year. Olanzapine LAI NDA accepted by FDA. Medincell focuses on long-acting injectable treatments across various therapeutic areas Medincell Teva Pharmaceuticals Olanzapine LAI UZEDY Long-acting Injectable
BRIEF published on 04/20/2026 at 11:18, 5 months 26 days ago BNP Paribas Développement crosses a threshold at MEDICELL Euronext Paris Voting Rights BNP Paribas Threshold Crossing MEDICELL
BRIEF published on 04/02/2026 at 19:05, 6 months 13 days ago Medincell: Update on capital and voting rights Share Capital Voting Rights Shares Euronext AMF
BRIEF published on 02/20/2026 at 21:42, 7 months 23 days ago Teva's Olanzapine Injectable Suspension Gains FDA Nod Schizophrenia Olanzapine Teva Pharmaceuticals FDA Acceptance Long-acting Injectable
Published on 10/16/2026 at 08:00, 3 hours 58 minutes ago Caledonia Mining Corporation Plc: Notification of Relevant Change to Significant Shareholder
Published on 10/16/2026 at 05:55, 6 hours 3 minutes ago Collective Metals Announces Private Placement of Hard Dollar and Flow-Through Units
Published on 10/16/2026 at 02:10, 9 hours 48 minutes ago Nova Scotia Silver Explorer TruSilver Metals Corp. Anticipates TSXV Trading Under "TAG" on October 27
Published on 10/16/2026 at 01:45, 10 hours 13 minutes ago Faraday Copper Closes the Acquisition of the San Manuel Project in Arizona and Mobilizes Drill Rigs
Published on 10/16/2026 at 01:30, 10 hours 28 minutes ago LNG Energy Group Announces Closing of Second Tranche of Private Placement
Published on 10/16/2026 at 11:45, 13 minutes ago OLB Appoints Johannes Knolle as Head of Acquisition Finance
Published on 10/16/2026 at 11:37, 20 minutes ago Verbio SE: Verbio marks 20 years since its IPO: from German biofuel pioneer to global green solutions business
Published on 10/16/2026 at 11:25, 32 minutes ago VINFAST'S OPENING IN EUROPE - PEOPLE WHO SWITCH TO ELECTRIC RARELY LOOK BACK
Published on 10/16/2026 at 11:00, 58 minutes ago Bosideng Makes Official Paris Fashion Week Debut with 50th Anniversary Show "The Bloom"
Published on 10/16/2026 at 10:30, 1 hour 28 minutes ago INmune Bio Inc. and Quantum Computing Inc. Partner to Apply Quantum Optimization and AI to Advance Alzheimer’s Drug Research and Explore New Applications for XPro
Published on 10/15/2026 at 18:50, 17 hours 8 minutes ago September & first 9 months of 2026 traffic figures - Revision of Traffic assumptions for 2026
Published on 10/15/2026 at 17:45, 18 hours 13 minutes ago DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
